1/4
1/4
💰 US Wealth: Tech gains boost the rich; others feel the squeeze.
🏗️ Business: Tech spending dwarfs traditional industry investment.
🌏 Asia: Exports (chips) thrive while domestic consumption lags.
💰 US Wealth: Tech gains boost the rich; others feel the squeeze.
🏗️ Business: Tech spending dwarfs traditional industry investment.
🌏 Asia: Exports (chips) thrive while domestic consumption lags.
📉 Price War: It’s priced significantly lower than the injectables.
⚔️ Competition: After losing ground to Eli Lilly, Novo is using the pill to reclaim lead.
🚀 Future: Oral meds are the new battleground for GLP-1.
📉 Price War: It’s priced significantly lower than the injectables.
⚔️ Competition: After losing ground to Eli Lilly, Novo is using the pill to reclaim lead.
🚀 Future: Oral meds are the new battleground for GLP-1.
Another point: What a massive fall (>50%) in Ola's market share.
Another point: What a massive fall (>50%) in Ola's market share.
1/2
1/2
The graduates of both countries tells a vastly different story.
The graduates of both countries tells a vastly different story.